Conference Coverage

High level of psychiatric morbidity in prodromal MS 


 

AT ACTRIMS FORUM 2023

When does MS start?

Commenting on the research findings, Mark Freedman, MD, professor of medicine (Neurology), University of Ottawa, and director of the multiple sclerosis research unit, Ottawa Hospital-General Campus, said the study illustrates the increased research attention the interplay between MS and psychiatric disorders is getting.

He recalled “one of the most compelling” recent studies that looked at a large group of children with MS and showed their grades started falling more than 5 years before developing MS symptoms. “You could see their grades going down year by year by year, so an indicator that a young brain, which should be like a sponge and improving, was actually faltering well before the symptoms.”

Results from this new study continue to beg the question of when MS actually starts, said Dr. Freedman.

The study received funding from the U.S. National MS Society, the MS Society of Canada, and the Michael Smith Foundation. Dr. Chertcoff and Dr. Freedman reported no relevant financial relationships.

A version of this article originally appeared on Medscape.com.

Pages

Recommended Reading

Four-gene signature linked to increased PML risk
MDedge Neurology
Stem cell transplant superior to DMTs for secondary progressive MS
MDedge Neurology
Despite ongoing challenges, experts are optimistic about the future of MS therapy
MDedge Neurology
Poor sleep quality as a teen may up MS risk in adulthood
MDedge Neurology
Biosimilar equal to natalizumab for relapsing remitting MS
MDedge Neurology
Health plans get very poor scores for access to autoimmune drugs
MDedge Neurology
CBT alone and with meds may decrease MS fatigue
MDedge Neurology
Differential diagnosis in MS: What to watch for
MDedge Neurology
To prevent MS, should we target EBV?
MDedge Neurology
MOGAD: Immunotherapy predicts fewer relapses
MDedge Neurology